OA01.03 Benmelstobart with Anlotinib plus Chemotherapy as First-line Therapy for ES-SCLC: A Randomized, Double-blind, Phase III Trial

Yuan‐Yuan Cheng, R Yang, J. Chen, W. Zhang, Chunguang Xie, Qing Hu, Ningning Zhou, Cibo Huang, Sheng Wei, Huaibo Sun,

Journal of Thoracic Oncology · 2023 · 12 citations · 0 references

DOIFull text

Open access

Concepts